Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Author:

Zhang Haijiao12ORCID,Wilmot Beth3,Bottomly Daniel3,Dao Kim-Hien T.2,Stevens Emily4,Eide Christopher A.25,Khanna Vishesh25,Rofelty Angela12,Savage Samantha12ORCID,Reister Schultz Anna12ORCID,Long Nicola12ORCID,White Libbey3ORCID,Carlos Amy6,Henson Rachel6,Lin Chenwei6,Searles Robert6,Collins Robert H.7,DeAngelo Daniel J.8,Deininger Michael W.9,Dunn Tamara10,Hein Than9,Luskin Marlise R.8,Medeiros Bruno C.10,Oh Stephen T.11ORCID,Pollyea Daniel A.12ORCID,Steensma David P.8,Stone Richard M.8,Druker Brian J.25ORCID,McWeeney Shannon K.3,Maxson Julia E.2,Gotlib Jason R.10,Tyner Jeffrey W.12ORCID

Affiliation:

1. Department of Cell, Developmental and Cancer Biology,

2. Division of Hematology and Medical Oncology, and

3. Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR;

4. Fred Hutchinson Cancer Research Institute, Washington University School of Medicine, Seattle, WA;

5. Howard Hughes Medical Institute, Chevy Chase, MD;

6. Integrated Genomics Laboratories, Oregon Health & Science University, Portland, OR;

7. Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX;

8. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;

9. Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;

10. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA;

11. Hematology Division, Department of Medicine, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO; and

12. Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, CO

Abstract

Abstract Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) are a group of rare and heterogeneous myeloid disorders. There is strong morphologic resemblance among these distinct diagnostic entities as well as a lack of specific molecular markers and limited understanding of disease pathogenesis, which has made diagnosis challenging in certain cases. The treatment has remained empirical, resulting in dismal outcomes. We, therefore, performed whole-exome and RNA sequencing of these rare hematologic malignancies and present the most complete survey of the genomic landscape of these diseases to date. We observed a diversity of combinatorial mutational patterns that generally do not cluster within any one diagnosis. Gene expression analysis reveals enrichment, but not cosegregation, of clinical and genetic disease features with transcriptional clusters. In conclusion, these groups of diseases represent a continuum of related diseases rather than discrete diagnostic entities.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3